Suppr超能文献

COVID-19患者气管切开术的结果

Outcome of Tracheostomy in COVID-19 Patients.

作者信息

Mishra Prasun, Jedge Prashant, Yadav Krutika V, Galagali Jeevan, Gaikwad Viraj, R Chethna, Kaushik Maitri

机构信息

Pune, Maharashtra India Department of Otorhinolaryngology, Bharati Vidyapeeth Medical College.

Pune, Maharashtra India Dept of Critical Care Medicine, Bharati Vidyapeeth Medical College.

出版信息

Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):404-408. doi: 10.1007/s12070-022-03248-1. Epub 2022 Nov 15.

Abstract

INTRODUCTION

Since the start of the COVID-19 pandemic 2019, quite a few patients became critical and needed ICU admission with ventilator assistance. Tracheostomy, which was initially performed late during the course of patient on ventilator, has now been considered a procedure that can be performed relatively early as this leads to early weaning of patients and overcomes the shortage of critical beds.

OBJECTIVE

This study aims to focus on the outcomes of tracheotomised COVID-19 patients in terms of survival and any tracheostomy related morbidity.

METHODS

A prospective study was performed on COVID-19 patients undergoing tracheostomy at this tertiary care teaching hospital, which also was a dedicated centre for treating COVID-19 patients. The duration of this study was from April 2020 to September 2021. Following tracheostomy, all patients were followed up regularly and clinical changes were recorded. Points that were specifically noted were timing of the tracheostomy, change in ventilator settings, tracheostomy related complications, requirement of oxygen, days needed to wean the patient, decanulation, and, if death, the cause of death.

RESULTS

A total of 136 surgical open tracheostomies were performed on COVID-19 patients over the study period. The mean duration of intubation (timing of tracheostomy) was 12 days. A total of 73 out of 136 (53.6%) patients survived. 51 patients (37.5%) got decannulated during the course of the hospital stay. 9 patients were decanulated during the follow up visits and 13 patients were lost to follow up. 63 out of 136 (46.3%) patients died due to COVID pneumonia. Most of the patients who died had gone into multi-organ failure. Air leak syndromes (pneumothorax and pneumomediastinum) were common findings. 10 patients already had surgical emphysema before taking up for tracheostomy and 6 developed 2-3 days after tracheostomy. The most common complication was bleeding, which was seen in 28 out of 136 patients. The Median weaning of period of patients who survived was 5 days.

CONCLUSION

Performing tracheostomy early in COVID-19 patients helps in early weaning of the patient from the ventilator and makes nursing care easier and increases the availability of ICU beds. The mortality rate was 46% amongst the 136 tracheostomies done in COVID-19 patients. Local site bleeding was the most common complication and surgical emphysema was also seen more than routine tracheostomies.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s12070-022-03248-1.

摘要

引言

自2019年新冠疫情开始以来,相当多的患者病情危重,需要入住重症监护病房并接受呼吸机辅助治疗。气管切开术最初是在患者使用呼吸机治疗后期进行的,现在被认为是一种可以相对早期进行的手术,因为这有助于患者早日脱机,并缓解重症床位短缺的问题。

目的

本研究旨在关注接受气管切开术的新冠患者的生存结果以及任何与气管切开术相关的发病率。

方法

在这家三级护理教学医院对接受气管切开术的新冠患者进行了一项前瞻性研究,该医院也是一家专门治疗新冠患者的中心。本研究的持续时间为2020年4月至2021年9月。气管切开术后,对所有患者进行定期随访,并记录临床变化。特别记录的要点包括气管切开术的时间、呼吸机设置的变化、与气管切开术相关的并发症、氧气需求、患者脱机所需天数、拔管情况,以及如果死亡,死亡原因。

结果

在研究期间,共对新冠患者进行了136例外科开放性气管切开术。平均插管时间(气管切开术时间)为12天。136例患者中有73例(53.6%)存活。51例患者(37.5%)在住院期间拔管。9例患者在随访期间拔管,13例患者失访。136例患者中有63例(46.3%)死于新冠肺炎。大多数死亡患者出现了多器官功能衰竭。漏气综合征(气胸和纵隔气肿)是常见的表现。10例患者在接受气管切开术前就已经出现手术性气肿,6例在气管切开术后2 - 3天出现。最常见的并发症是出血,136例患者中有28例出现出血。存活患者的中位脱机时间为5天。

结论

在新冠患者早期进行气管切开术有助于患者早日从呼吸机上脱机,使护理工作更轻松,并增加重症监护病房床位的可用性。在136例接受气管切开术的新冠患者中,死亡率为46%。局部出血是最常见的并发症,手术性气肿的发生率也高于常规气管切开术。

补充信息

在线版本包含可在10.1007/s12070 - 022 - 03248 - 1获取的补充材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6755/10235334/113b955c5604/12070_2022_3248_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验